https://www.selleckchem.com/pr....oducts/gsk2830371.ht
405 allografts were explanted for structural failure, actuarially 2%, 14%, 34%, and 51% at 5, 10, 15, and 20 years. Risk factors for structural failure were younger recipient age, larger body surface area, hypertension, and thoracic aorta disease; donor factors were older age and larger allograft size. Implant for infective endocarditis was not associated with accelerated structural failure. This study affirms allografts' long-term acceptable hemodynamic performance and durability. Concern about structural failure should not limit al
Like
Comment
Share
